Ligand Pharmaceuticals' Q3 2024 earnings report beat on the top and bottom lines, reinforcing my confidence. Read what makes ...

Wolfe Research has recently initiated Amgen Inc (AMGN) stock to Peer Perform rating, as announced on November 15, 2024, according to Finviz. Earlier, on November 14, 2024, Citigroup had initiated the ...

BMO Capital analyst Evan Seigerman has maintained their bullish stance on AMGN stock, giving a Buy rating yesterday.Don't Miss our Black ...

The world of pharmacenutical stocks has a lot to offer investors. With their resilience in the face of economic issues and ...

Lowering BMI alone may reduce the risk of various obesity-related diseases, but other factors might also play a role. A new ...

In the trial, 20% of patients didn’t respond well to the PCSK9 inhibitor—could genetic markers be used to tailor therapy?

Howard Chang will take over as chief scientific officer and senior VP of research as the biotech searches for more ways to ...

Some industry leaders are confident health care products such as drugs will be carved out of expected Trump administration tariffs ...

Check out five New York companies hiring biopharma professionals like you, including 2025 Best Places to Work winners.

Recent developments in health news highlight the CDC's anticipation of increased COVID-19 and RSV cases during the holidays, ...

Upcoming data from a mid-stage study of Amgen's experimental weight-loss drug MariTide will shed light on how well it might ...

Upcoming data from a mid-stage study of Amgen's experimental weight-loss drug MariTide will shed light on how well it might ...